Serum immunoglobulin levels in Artemis patients
| Patient ID | Diagnosis | Age at sampling | B cell count | Serum Ig levels (g/liter) | Artemis mutations | References | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| % | IgM | IgG | IgA | |||||||
| A1 | T−B−NK+ SCID | 5 mo | <0.01 | NAa | NA | NA | deletion of exon 10, 11, 12 (ho) | (42) | ||
| A7 | T−B−NK+ SCID | 7 mo | 0 | <0.04 | 3.38b | <0.07 | deletion of exon 1, 2, 3 (ho) | (43) | ||
| A8 | T−B−NK+ SCID | 6 mo | <0.01 | 0.13 | 5.7b | 0.1 | 1391-1395delGAATC (ho) | (39) | ||
| AKE | CID | 4 yr | 33c | 2.3 | <2.0 | <0.4 | 207-209delGTT (he)/377G>A (he) | (22, 25) | ||
| Patient ID | Diagnosis | Age at sampling | B cell count | Serum Ig levels (g/liter) | References | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| IgM | IgG | IgA | ||||||||
| A1 | T−B−NK+ SCID | 5 mo | <0.01 | NA | NA | NA | deletion of exon 10, 11, 12 (ho) | ( | ||
| A7 | T−B−NK+ SCID | 7 mo | 0 | <0.04 | 3.38 | <0.07 | deletion of exon 1, 2, 3 (ho) | ( | ||
| A8 | T−B−NK+ SCID | 6 mo | <0.01 | 0.13 | 5.7 | 0.1 | 1391-1395delGAATC (ho) | ( | ||
| AKE | CID | 4 yr | 33 | 2.3 | <2.0 | <0.4 | 207-209delGTT (he)/377G>A (he) | ( | ||